BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) has been given a consensus rating of “Moderate Buy” by the fifteen analysts that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $18.50.
BTSG has been the subject of a number of research reports. KeyCorp started coverage on shares of BrightSpring Health Services in a research report on Friday, October 11th. They set a “sector weight” rating for the company. UBS Group upped their target price on BrightSpring Health Services from $16.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. BTIG Research raised their price target on BrightSpring Health Services from $15.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Bank of America upped their price objective on BrightSpring Health Services from $19.00 to $21.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Finally, Wells Fargo & Company lifted their price objective on BrightSpring Health Services from $17.00 to $21.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th.
View Our Latest Stock Analysis on BTSG
Institutional Trading of BrightSpring Health Services
BrightSpring Health Services Stock Performance
BTSG opened at $18.56 on Monday. The stock’s 50 day simple moving average is $17.49 and its 200 day simple moving average is $14.08. The stock has a market cap of $3.23 billion and a P/E ratio of -71.38. BrightSpring Health Services has a 1-year low of $7.85 and a 1-year high of $20.25. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last posted its earnings results on Friday, November 1st. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.07). BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The firm had revenue of $2.91 billion during the quarter, compared to analyst estimates of $2.72 billion. BrightSpring Health Services’s revenue for the quarter was up 28.8% compared to the same quarter last year. As a group, equities analysts anticipate that BrightSpring Health Services will post 0.59 EPS for the current fiscal year.
About BrightSpring Health Services
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Featured Articles
- Five stocks we like better than BrightSpring Health Services
- Do ETFs Pay Dividends? What You Need to Know
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- How to Evaluate a Stock Before Buying
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.